Request Sample

Global Hemoglobin A1c (Hba1c) Testing Devices Market

May 22, 2019

Global Hemoglobin A1c (Hba1c) Testing Devices Market, By Test Type (Point-of-Care Testing Devices and Laboratory Testing Devices), By Device Type (Bench-Top Device and Handheld Device), By Technology Type (Enzymatic Assay, Turbidimetric Inhibition Immunoassay, Ion-exchange High Performance Liquid Chromatography (HPLC), Affinity Binding Chromatography, Direct Enzymatic Assay, Boronate Affinity Chromatography, and Others), By End User (Homecare, Diagnostic Laboratory, Hospitals, and Research Institutions ), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa)- Global Forecast, 2020-2025.

Report Code :FMR518      
Pages :210 Pages
Format :   PPT Format   PDF Format

The global hemoglobin A1c (HbA1c) testing devices market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020 and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Hemoglobin A1c (HbA1c) is an ordinary blood test, which is performed to diagnose the patients and monitor the diabetes of both Type 1 and Type 2. The increase in the diabetes disease and amount of HbA1c in the bloodstream of patients is the key factor to lead the growth of the hemoglobin A1c (HbA1c) testing device market. For instance, in October 2016, according to the experts and scientists’ studies, HbA1c acts as a gold standard measurement of diabetes outcomes, and therefore, it thrives the demand for the hemoglobin A1c (HbA1c) testing device market.

Table 1. Global Hemoglobin A1c (Hba1c) Testing Devices Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Test Type)

Point-of-Care Testing Devices and Laboratory Testing Devices

Market Segmentation (By Device Type)

Bench-Top Device and Handheld Device

Market Segmentation (By Technology Type)

Enzymatic Assay, Turbidimetric Inhibition Immunoassay, Ion-exchange High Performance Liquid Chromatography (HPLC), Affinity Binding Chromatography, Direct Enzymatic Assay, Boronate Affinity Chromatography, and Others

Market Segmentation (By End User)

Homecare, Diagnostic Laboratory, Hospitals, and Research Institutions

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East and Africa

Key Players Coverage

Arkray, Abbott Laboratories, Inc., Trinity Biotech Plc, Alere, Bio-Rad Laboratories, Siemens Healthcare, Chek Diagnostics, Menarini Group, Danaher Corporation, F. Hoffmann-La Roche Ltd., Tosoh Corporation, and Transasia Biomedicals Ltd., among others

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

The rising health infrastructure, innovations, and regulatory approval of healthcare initiatives by the companies and due to the demand by the patients and individuals to get easy access to testing leads to uplift the demand for the hemoglobin A1c (HbA1c) testing devices market. The facilities of the manufacturers and healthcare providers to access the test at home or office for patients increase the growth for hemoglobin A1c (HbA1c) testing devices market. For instance, in October 2018, PTS Diagnostics, a manufacturer of point-of-care testing devices, got approval for its newly developed system i.e., A1cNow, which provides the facility to get an access of test at home and received the accurate results at home or office.

The increase in the launches of efficient and advanced testing devices and receiving an approval by the regulatory bodies thrive the growth of the hemoglobin A1c (HbA1c) testing devices market. For instance, in September 2015, the company Bio-Rad Laboratories announced approval from U.S. FDA (Food and Drug Administration) for VARIANT II TURBO HbA1c system, which provides fully automated high-volume hemoglobin A1c and identifies the patients suffering from diabetes to their proper diabetes aid.

However, the low diagnostic performance of tests during pregnancy, lack of awareness, and the high cost of testing services are expected to hamper the hemoglobin A1c (HbA1c) testing devices market over the forecasted period.

Figure 1. PORTER’S Analysis

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

North America is expected to witness the lucrative growth of the hemoglobin A1c (HbA1c) testing devices market owing to the favorable facilities for the patients and individuals, such as diagnosis of test at home, and development of new system. and the reduction of price of testing devices. For instance, in October 2018, PTS Diagnostics declared about the updating facility of A1cNow Self Check system by making the number of A1c tests twice per package of $10 to $50. This lowers the average cost per test of A1c Home Monitoring System, which leads to pave the significant growth of hemoglobin A1c (HbA1c) testing devices market in this region.

Moreover, increasing incidences of diabetes and approval of regulatory in the region are anticipated to raise the demand for the hemoglobin A1c (HbA1c) testing devices market. Companies are launching or developing systems to increase their product portfolio and services of treating diabetes in the Asia-Pacific region. For instance, in June 2019, Abbott Laboratories launched Afinion HbA1c Dx assay as a first ever rapid point-of-care HbA1c test to diagnose the patients suffering from diabetes.

Figure 2. Regional Analysis

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitive Landscape

Key players in the global hemoglobin A1c (HbA1c) testing devices market include Arkray, Abbott Laboratories, Inc., Trinity Biotech Plc, Alere, Bio-Rad Laboratories, Siemens Healthcare, Chek Diagnostics, Menarini Group, Danaher Corporation, F. Hoffmann-La Roche Ltd., Tosoh Corporation, and Transasia Biomedicals Ltd., among others

Various companies are adopting the product launching strategy to expand their product portfolio of HbA1c testing devices.  For instance, in September 2018,  ARKRAY declared the launch of the ADAMS Alc HA-8180V system for hemoglobin A1c (HbA1c) testing to aid or treat the diabetic patients.

Furthermore, in May 2019, Siemens Healthcare launched a new system i.e., Atellica CH Enzymatic hemoglobin A1c assay to diagnose and monitors the diabetes suffering patients.

Figure 3. Market Share of Key Players, 2019

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

By Test Type

  • Point-of-Care Testing Devices
  • Laboratory Testing Devices

By Device Type

  • Bench-Top Device
  • Handheld Device

By Technology Type

  • Enzymatic Assay
  • Turbidimetric Inhibition Immunoassay
  • Ion-exchange High Performance Liquid Chromatography (HPLC)
  • Affinity Binding Chromatography
  • Direct Enzymatic Assay
  • Boronate Affinity Chromatography
  • Others

By End User

  • Homecare
  • Diagnostic Laboratory
  • Hospitals
  • Research Institutions

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global hemoglobin A1c (HbA1c) testing devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global hemoglobin A1c (HbA1c) testing devices market?
  • What key factors are expected to increase the demand for hemoglobin A1c (HbA1c) testing devices market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global hemoglobin A1c (HbA1c) testing devices market?
  • What was the total market value (US$ Mn) generated in global hemoglobin A1c (HbA1c) testing devices market by test type in 2019, and what are the forecasts by 2025?
  • What is the total market value (US$ Mn) generated in global hemoglobin A1c (HbA1c) testing devices market by device type in 2019 and what are the forecasts by 2025?
  • What is the total market value (US$ Mn) generated in global hemoglobin A1c (HbA1c) testing devices market by technology type in 2019 and what are the forecasts by 2025?
  • Which end user contributes highest CAGR (%) in the hemoglobin A1c (HbA1c) testing devices bank market?
  • What was the total revenue generated by the global hemoglobin A1c (HbA1c) testing devices market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global hemoglobin A1c (HbA1c) testing devices market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the hemoglobin A1c (HbA1c) testing devices market?
  • What are the major outcomes derived from the Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have huge impact on the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.